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Summary
Objectives: Osteophytes represent areas of new cartilage and bone formation in human and experimentally induced osteoarthritis (OA). The
present study addressed the production of nitric oxide (NO), vascular endothelial growth factor (VEGF) and the occurrence of apoptosis
during osteophyte formation.
Design: Osteophytes in the knee joint of rabbits that developed OA-like lesions following anterior cruciate ligament transection (ACLT) were
analysed by histology and immunohistochemistry for NO production, and the presence of VEGF. TUNEL was used to detect DNA
fragmentation.
Results: At the joint margins in the interface between cortical bone marrow and periosteal lining growth plate-like formations were detectable
as early as 4 weeks after ACLT. By 12 weeks after ACLT osteophytes were visible in 100% of femoral condyles and tibial plateaus. Discrete
areas with proliferating chondrocytes, hypertrophic chondrocytes, calcified matrix and vascular invasion were observed. VEGF immuno-
reactivity was most prominent in hypertrophic chondrocytes 9 weeks after ACLT. Nitrotyrosine immunoreactivity was detected in endothelial
cells and in some hypertrophic chondrocytes in the calcified zone 4 weeks after ACLT. After 8 and 12 weeks, positive cells were detected in
the hypertrophic and calcified zone. TUNEL-positive cells were seen in blood vessels, and among hypertrophic chondrocytes adjacent to the
blood vessels 4 weeks after ACLT. The proliferative zone, pre-hypertrophic zone and hypertrophic zone showed only a few TUNEL positive
cells. In contrast, 8 weeks and 12 weeks after ACLT, most hypertrophic chondrocytes, but few proliferative chondrocytes showed DNA
fragmentation.
Conclusions: Hypertrophic chondrocytes in osteophytes express VEGF and this can promote vascular invasion of cartilage. The presence
of TUNEL-positive cells shows a similar distribution as nitrotyrosine immunoreactivity during all phases of osteophyte development,
suggesting that NO production and chondrocyte death are related events in osteophyte formation. © 2002 OsteoArthritis Research Society
International
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Joints affected by osteoarthritis (OA) are not only charac-
terized by the degradation of existing cartilage matrix but
also by the production of new connective tissue in the form
of osteophytes on the joint surface and more notably at the
joint margins1. Osteophytes, also referred to as chondro-
osteophytes, are also observed in experimentally induced
arthritis2–4. Osteophytes can limit joint movement and
represent a source of joint pain5. Their formation has been
interpreted as an adaptation of the joint to the altered
biomechanics of OA joints6,7. However, it is important to
note that when osteophytes appear in the absence of other
bone changes, they may not be a manifestation of OA and
not predict radiographic progression of joint damage8.
Osteophytes have also been detected in the intercondylar
notch of human knees that did not show OA cartilage180degradation9 and in patients with anterior cruciate ligament
rupture, osteophytes developed before changes in joint
space width were detected10.
The initial stimuli for osteophyte formation are not
defined but mechanical11,12 and humoral13 factors are
probably involved. Repeated injections of mouse joints with
TGF or BMP14 induced osteophytes or enhanced osteo-
phyte formation in animals with experimentally induced OA.
After repeated injections into normal mouse joints, both
BMP-2 and TGF1 induced chondrogenesis at specific
sites. Chondrophytes induced by BMP-2 were found pre-
dominantly in the region where the growth plates meet the
joint space, while those triggered by TGF1 originated from
the periosteum also at sites remote from the growth
plates14,15. TGF, bFGF and IGF-1 were detected in
osteophytes16–18.
Osteophytes are composed of cells that express type I
procollagen mRNA, mesenchymal prechondrocytes that
express type IIA procollagen mRNA, and maturing
chondrocytes that express type IIB procollagen mRNA.
Based on the spatial pattern of gene expression and
cytomorphology, the neochondrogenesis associated with
osteophyte formation closely resembles that of healing
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EXPERIMENTAL OSTEOARTHRITIS
Mature New Zealand White rabbits, aged 12 months
were used in the present study. All rabbits were anesthe-
tized by an intramuscular injection of ketamine (100 mg/kg)
and zylazine (8 mg/kg). Knees were shaved and disin-
fected with Betadine solution. A medial parapatellar incision
was made on the skin and a medial arthrotomy was
performed. The patella was dislocated laterally and the
knee placed in full flexion. The anterior cruciate ligament
(ACL) was visualized and transected with a #15 blade. The
joint was irrigated with sterile saline and closed. Thecapsule was closed with a running suture of 4-0 prolene
and the skin was closed with a running mattress suture
supplemented with interrupted sutures of 3-0 nylon. The
contralateral side was not subjected to any surgical
manipulation. Post-operatively, the animals were permitted
cage (60 cm×60 cm×40 cm) activity without immobiliza-
tion. The animals were closely monitored for infections and
other complications. Cartilage was also harvested from
normal rabbits that were not subjected to ACL transection.GROSS MORPHOLOGY
Rabbits were sacrificed 4, 9 and 12 weeks after ACL
transection. After sacrifice, both knees were harvested. The
occurrence, site and severity of cartilage lesions and
formation of osteophytes on the femoral condyles were
mapped on a schematic representation of the rabbit knee.
Gross morphological changes of the femoral condyles were
assessed by established criteria37 following the application
of India ink: grade 1 (intact surface): surface appears
normal and does not retain any ink; grade 2 (minimal
fibrillation): site appears normal before staining, but retains
the India ink as elongated specks or light gray patches;
grade 3 (overt fibrillation): the cartilage is velvety in appear-
ance and retains ink as intense black patches; grade 4
(erosion): loss of cartilage exposing the underlying bone.TISSUE PROCESSING AND HISTOLOGY
Tissue blocks were fixed in 10% neutral buffered
formalin with cetylpyridinium chloride (CPC) for 7 days and
decalcified with EDTA. After decalcification (confirmed by
X-ray), the femoral condyles were cut along the saggital
plane and medial condyles were embedded in paraffin. Five
micron sections were cut with a Reichert-Jung microtome
and stained with hematoxylin and eosin (H&E), Safranin
O/fast green under the following condition: dye concen-
tration 0.1%, staining time 6 minutes, pH 5.7. All staining
processes were performed at room temperature.Table I
Gross morphology OA grade and osteophyte
0 weeks 4 weeks 8 weeks 12 weeks
Femoral condyle
OA grade I: 100% II: 60%, III: 40% III: 50%, IV: 50% II: 10%, III: 30%
IV: 60%
Osteophyte L: 0%, M: 0% L: 100%, M: 100% L: 100%, M: 100% L: 100%, M: 100%
Tibial plateau
OA grade I: 100% I: 60%, II: 20% II: 30%, III: 60% III: 40%, IV: 60%
III: 20% IV: 10%
Osteophyte L: 0%, M: 0% L: 80%, M: 60% L: 90%, M: 90% L: 100%, M: 100%
The frequency of osteophytes and the severity of cartilage degradation was assessed 0, 4, 8 and 12 weeks
after ACLT. L: lateral; M: medial.
The results are from the analysis of 6 rabbits per time point.IN SITU DETECTION OF NDA FRAGMENTATION
Cartilage sections were fixed in 10% neutral buffered
formalin for 15 h and embedded in paraffin. Sections (5 m
thickness) were floated onto poly-L-lysine coated slides. In
situ detection of apoptosis was performed using the Apofracture callus19–21 and is also similar to the epiphyseal
growth plate22. An area of proliferating cells can be dis-
tinguished from layers with differentiating and terminally
differentiated hypertrophic chondrocytes that express type
X collagen. This area is vascularized and can undergo
endochondral ossification22,23.
Recent studies on growth plate have provided new
insight into the cellular events and their regulation at the
interface of hypertrophic cells and vascular invasion.
Growth factors that regulate vascular invasion and
chondrocyte hypertrophy have been defined. Vascular
endothelial cell growth factor (VEGF) has been shown to
regulate hypertrophic cartilage remodeling, ossification and
vascular invasion of growth plate cartilage24. Vascular
invasion is histologically linked to the development
of apoptosis in differentiated chondrocytes of growth
plate25–27 and fracture callus28,29. Apoptosis is thought to
represent a physiological event in the process of matrix
mineralization, possibly through the formation of matrix
vesicles30.
Chondrocyte apoptosis also occurs in osteoarthritic
articular cartilage and in this context is associated with
matrix degradation and calcification30–33. Apoptosis can be
induced in articular cartilage by nitric oxide34. OA cartilage
contains iNOS expressing cells and produces NO spon-
taneously in vitro35. Nitrotyrosine immunoreactivity can be
detected as an indicator of peroxynitrite formation36. The
production of NO in growth plate and its relationship to
apoptosis have not been examined.
The present study examined chondrocyte death, NO
production and VEGF expression in osteophytes during
experimentally induced OA in rabbits after anterior cruciate
ligament transaction (ACLT).
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Osteoarthritis and Cartilage Vol. 10, No. 3 183Tag kit (Oncor, Gaithersburg, MD). In brief, sections were
digested with proteinase K (20 g/ml) for 15 min at room
temperature. Sections were then pre-treated with
bovine testicular hyaluronidase (0.5 mg/ml at 37°C for
30 min). DNA was end-labeled with digoxygenin-labeled
dUTP using terminal transferase and detected with
peroxidase-conjugated anti-digoxigenin antibody (Oncor).
In the negative control terminal transferase was
omitted. Adjacent sections were stained with H&E and
Safranin O.IMMUNOHISTOCHEMISTRY FOR NITROTYROSINE AND VEGF
Sections were pretreated with bovine testicular
hyaluronidase (0.5 mg/ml at 37°C for 30 min) and incu-
bated in 5% normal goat serum at room temperature for
20 min. Presence and distribution of nitrotyrosine were
determined by the avidin/biotin peroxidase (ABC) method
using rabbit anti-nitrotyrosine antibody (Upstate, Lake
Placid, NY) and anti-VEGF (Oncogene, Cambridge MA) as
primary antibody. The antibody was generated by immuniz-
ing mice with human recombinant VEGF121. It recognizes
proteins of 34–50 kDa identified as the various isoforms
of VEGF. A biotinylated goat antirabbit antibody (Vector
Laboratories, Burlingame, CA) was used as secondary
antibody. Levamisole was added to block endogenous
alkaline phosphatase. The negative control consisted of
non-immune rabbit serum as a substitute for the primary
antibody.Results
THE DEVELOPMENT OF OSTEOPHYTES FOLLOWING ANTERIOR
CRUCIATE LIGAMENT TRANSECTION
Four weeks after ACLT, osteophytes were visible at
100% of femoral condyles, 80% of the lateral tibial plateaus
and in 60% of the medial tibial plateaus by gross morpho-
logical observation (Table I). In normal rabbit knees a
transition from cartilage to perichondrium and periosteum is
seen at the joint margin [Fig. 1(a),(b)]. Already, 4 weeks
after ACLT, new cell formations were observed at the
interface between bone marrow and the inner aspect of the
periosteum [Fig. 1(c),(d)]. Cells were aligned in columns
and cell size increased towards the bone marrow. New
blood vessels intersected the area of hypertrophic cells
[Fig. 1(e)]. This overall structure was similar to the epiphy-
seal growth plate. Nine weeks after ACLT osteophytes were
seen in 90% of tibial plateaus and their size was increased
(Table I). Newly formed bone tissue was observed at the
calcified zone [Fig. 1(f),(g)]. After 12 weeks, osteophytes
were visible in all femoral condyles and tibial plateaus
(Table I). The calcified zone and new bone tissue were
further enlarged and osteoblasts and multinucleated
osteoclast-like cells could be distinguished at the leading
front of vascularization [Fig. 1(h),(i)].Fig. 2. VEGF expression in osteophytes. Panel (a): Normal joints: a small number of cells in the synvovial lining express VEGF (×400). Panel
(b): 4 weeks after ACLT: hypertrophic chondrocytes in the hypertrophic zone of osteophytes adjacent to new blood vessels express VEGF
(×400; V: blood vessel). Panel (c): 9 weeks after ACLT large numbers of hypertrophic chondrocytes in osteophytes express VEGF (×400).
Panel (d): Osteophyte 4 weeks after ACLT, control stain with rabbit pre-immune IgG (×400).VEGF EXPRESSION IN CHONDROCYTES AND ANGIOGENESIS
VEGF has recently been shown to be expressed in
hypertrophic cartilage in the growth plate and to coordinate
184 S. Hashimoto et al.: Development and regulation of osteophyte formationhypertrophy, vascular invasion and angiogenesis24. In nor-
mal joints only a small number of cells in the transition zone
at the joint margin expressed VEGF [Fig. 2(a)]. Four weeks
after ACLT new blood vessels had formed adjacent to
hypertrophic chondrocytes. A small number of these hyper-
trophic cells were positive for VEGF [Fig. 2(b)]. Nine weeks
after ACLT there were more blood vessels and now a large
number of hypertrophic chondrocytes were expressing
VEGF [Fig. 2(c)]. Some of the vascular cells were also
positive for VEGF.Fig. 3. Nitrotyrosine immunoreactivity in osteophytes. Panels (a),(b): 4 weeks after ACLT: nitrotyrosine immunoreactivity was detected in
endothelial cells and some hypertrophic chondrocytes [Panel (a) ×100; Panel (b) ×400]. Panel (c),(d): 9 weeks after ACLT the number of
nitrotyrosine positive cells was increased in the degenerative, hypertrophic and calcified zone [Panel (c) ×100; Panel (d) ×400]. Panel (e),(f):
12 weeks after ACLT the number of cells and intensity of nitrotyrosine immunoreactivity in the hypertrophic zone increases further.
h=hypertrophic; M=mineralizing [Panel (e) ×100; Panel (f) ×400].NITROTYROSINE FORMATION
Nitric oxide reacts with superoxide radical to form peroxy-
nitrite. In tissue or biological fluids peroxynitrite leads to
the nitration of aromatic amino acid residues and this may
be a marker of peroxynitrite-mediated, NO-dependent
damage in vivo36. Nitrotyrosine immunoreactivity was
detected in vascular cells and some hypertrophic chondro-
cytes in the osteophytes 4 weeks after ACLT [Fig. 3(a),(b)].
After 9 and 12 weeks, a large number of nitrotyrosine
Osteoarthritis and Cartilage Vol. 10, No. 3 185positive cells was present in the hypertrophic and in the
calcified zone [Fig. 3(c)–(f)].DNA FRAGMENTATION IN OSTEOPHYTES
Osteophytes that had developed 4 weeks after ACLT
showed DNA fragmentation among some cells in blood
vessels and hypertrophic chondrocytes close to the blood
vessels [Fig. 4(a),(b)]. The proliferative zone, pre-
hypertrophic zone and non-calcified hypertrophic zone
showed only few apoptotic cells. Nine and 12 weeks after
ACLT almost all cells in the hypertrophic zone and alsosome cells in the proliferative zone were undergoing
apoptosis [Fig. 4(c)–(f)].Fig. 4. DNA fragmentation in osteophytes. Panels (a),(b): 4 weeks after ACLT some vascular cells and a small number of hypertrophic
chondrocytes were TUNEL positive [(a) ×100; (b) ×400]. Panels (c),(d): 9 weeks after ACLT most hypertrophic chondrocytes and few
proliferative chondrocytes and many vascular cells were TUNEL positive [(c) ×100; (d) ×400]. Panels (e),(f): Many vascular cells and
hypertrophic chondrocytes are TUNEL positive [(e) ×100; (f) ×400]. h=hypertrophic; M=mineralizing.CO-LOCALIZATION OF DNA FRAGMENTATION AND NITROTYROSINE
IMMUNOREACTIVITY
DNA fragmentation and nitrotyrosine immunoreactivity
showed similar distribution in the osteophytes. Double
staining revealed that many TUNEL-positive cells
were also positive for nitrotyrosine during all phases of
osteophyte development (Fig. 5).
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Similarities in histologic appearance and regulatory path-
ways have been noted among the epiphyseal growth plate
and osteophytes22. Chondrocyte hypertrophy, degenera-
tion and vascular invasion with eventual replacement with
new bone tissue are well characterized and mechanistically
related events in growth plate25,38. The present study
analysed whether VEGF and nitric oxide production can be
detected in osteophytes and whether their expression is
associated with chondrocyte death and matrix calcification.
The results show that hypertrophic chondrocytes in
osteophytes express VEGF. In growth plate, hypertrophic
chondrocytes produced VEGF and VEGF mediated capil-
lary invasion is an essential signal that regulates chondro-
cyte differentiation and triggers cartilage remodeling24.
VEGF inhibition expanded the layer of hypertrophic
chondrocytes and inhibited or delayed apoptotic cell death
in growth plate. The subchondral vascular system has a
pivotal role in the regulation of endochondral ossification.
Marginal osteophytes form when capillaries penetrate
the subchondral bone and deep zone of articular cartilage.
VEGF is thus likely to be an important regulator of
angiogenesis during osteophyte development.
The so-called degeneration of chondrocytes in the
hypertrophic zone is associated with DNA fragmentation.
Cells with fragmented DNA were detected in the hyper-
trophic zone, while few cells were found in the proliferative
zone. It is possible that at least some of the cells that are
TUNEL positive are undergoing apoptosis. The formation ofmineralizing matrix vesicles may thus also be a conse-
quence of apoptosis in the osteophyte. Both chondrocyte-
derived apoptotic bodies and matrix vesicles contain
enzymatic activities that are required for calcium depo-
sition30. Apoptosis in terminally differentiated growth plate
chondrocytes has been reported by several labora-
tories26,38. The presence of TUNEL-positive cells in blood
vessels may indicate that the involution of blood vessels
occurs via apoptosis.
Nitrotyrosine immunoreactivity showed a similar distribu-
tion as apoptotic cells. In our previous studies, exogenous
NO induced apoptotic cell death in cultured chondro-
cytes34, and the presence of apoptotic chondrocytes
correlated with NO production during experimental OA33.
The present findings suggest that VEGF secreted from
hypertrophic chondrocytes induced capillary invasion into
the hypertrophic zone, calcified zone and subchondral
zone from bone marrow. During the early phases (4 weeks
after ACLT) endothelial cell derived NO may induce
apoptosis in hypertrophic chondrocytes around blood
vessels. At later phases (9 and 12 weeks), almost all
degenerative and hypertrophic chondrocytes were
nitrotyrosine-positive and these cells TUNEL-positive.
Thus, NO production, may lead to chondrocyte apoptosis
and both events contribute to the pathogenesis of cartilage
degradation and osteophyte formation in the same joint.
Inhibitors of NO synthesis were shown to reduce the
progression of cartilage lesions, as well as the presence
and size of osteophyte in experimental OA39 and iNOS
deficiency in mice with OA induced by intraarticular injec-
tion of collagenase was associated with reduced cartilage
pathology and reduced osteophyte formation40.
In conclusion, osteophyte formation during experimen-
tally induced OA is associated with the expression of
VEGF in chondrocytes. This provides a signal for vascular
invasion of the cartilage and is followed by nitric oxide
production, chondrocyte death and matrix calcification.Fig. 5. Nitrotyrosine immunoreactivity and DNA fragmentation in
osteophytes. Panel (a): 4 weeks after ACLT osteophyte stained
with pre-immune rabbit IgG. Panel (b): Osteophyte 4 weeks after
ACLT stained with nitrotyrosine and TUNEL (×400).References
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